Clinical Trial

"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.

Study acronym: MaVie
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Principal Investigator's departure
Summary
Since late 2019, the French association "MON PARCOURS DE VIE" has developed books donated by caregivers at cancer centers in France. These documents are available online: https://www.monparcoursdevie.fr/. They are highly acclaimed by women suffering from the breast cancer, as well as by caregivers. Four volumes have been written: 'Metastatic breast cancer', 'Localized breast cancer', 'Preserving my well-being', 'After breast cancer', and finally 'Breast cancer, support and accompaniment'. The aim in writing these information brochures is to provide clear, concise, useful information, with pedagogy, gentleness, benevolence, humility, cheerfulness, imagination, simplicity and an innovative presentation. These documents are a new and innovative method of providing information, delivered by caregivers who work with women suffering from breast cancer. It extends the human support so necessary in this disease. It seemed important to us to evaluate, through a clinical study, the impact of the written documents "Mon Parcours de Vie" - volume 2: Breast cancer and volume 3: Preserving my well-being, concerning the announcement of a localized breast cancer in the initial management for the first time in the breast pathway. The objectives of the clinical study are to evaluate the acceptability and impact of these two written information documents on anxiety generated by the announcement of cancer and treatment.
Protocol Amendment History 5 changes
critical Trial terminated 2026-08-07
critical Trial terminated: Principal Investigator's departure 2026-08-07
notable Enrollment reduced: 60 -> 34 participants 2026-08-07
notable Primary completion moved earlier: 2026-06-01 -> 2026-04-02 2026-08-07
minor Completion moved earlier: 2026-11-01 -> 2026-08-02 2026-08-07
Trial Details
NCT Number NCT07165756
Lead Sponsor Institut de Cancérologie de Lorraine
Conditions Localized Breast Cancer
Enrollment 34 participants
Start Date 2025-09-09
Primary Completion 2026-04-02 (estimated)
Study Completion 2026-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-06